Corient Private Wealth LP Makes New $60.31 Million Investment in CME Group Inc. $CME

Corient Private Wealth LP acquired a new position in CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 1,019,758 shares of the financial services provider’s stock, valued at approximately $60,314,000. Corient Private Wealth LP owned 0.28% of CME Group at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in shares of CME Group in the second quarter worth $6,749,965,000. State Street Corp raised its stake in shares of CME Group by 0.4% during the fourth quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock valued at $4,408,747,000 after acquiring an additional 56,725 shares during the last quarter. Norges Bank purchased a new stake in shares of CME Group during the fourth quarter worth about $1,523,241,000. Bank of New York Mellon Corp grew its stake in shares of CME Group by 2.8% in the fourth quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock worth $1,344,776,000 after purchasing an additional 134,242 shares during the last quarter. Finally, Raymond James Financial Inc. increased its holdings in CME Group by 5.4% during the 4th quarter. Raymond James Financial Inc. now owns 4,319,763 shares of the financial services provider’s stock valued at $1,179,858,000 after purchasing an additional 222,890 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director William R. Shepard acquired 325 shares of CME Group stock in a transaction on Thursday, June 25th. The stock was acquired at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the purchase, the director owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Down 0.0%

Shares of NASDAQ:CME opened at $280.94 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a fifty day simple moving average of $253.01 and a two-hundred day simple moving average of $279.09. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The stock has a market capitalization of $101.02 billion, a price-to-earnings ratio of 23.83, a PEG ratio of 3.34 and a beta of 0.23.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company’s quarterly revenue was up .8% on a year-over-year basis. During the same period in the prior year, the firm posted $2.96 earnings per share. On average, research analysts anticipate that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio is 44.11%.

Analyst Ratings Changes

A number of analysts recently commented on the company. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and raised their price target for the stock from $316.00 to $323.00 in a research note on Thursday, June 11th. TD Cowen reduced their price target on shares of CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Barclays decreased their price target on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research note on Thursday, July 9th. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a report on Thursday, June 18th. Finally, Wall Street Zen cut CME Group from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 1st. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $288.56.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.